A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2002
08/22/2002	WO2002064160A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof
08/22/2002	WO2002064146A1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
08/22/2002	WO2002064121A1 Novel modified released formulation
08/22/2002	WO2002064118A1 Novel modified release formulation
08/22/2002	WO2002064109A2 Mucoadhesive pharmaceutical formulations
08/22/2002	WO2002064094A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
08/22/2002	WO2002064092A2 Method for evaluating therapeutic efficacy
08/22/2002	WO2002064083A2 Synthesis of 3-amino-thalidomide and its enantiomers
08/22/2002	WO2002064080A2 Matrix metalloproteinase inhibitors
08/22/2002	WO2002064063A1 Bioartificial device for storing, cultivating and/or reproducing cells
08/22/2002	WO2002042280A3 Pyrimidine derivatives
08/22/2002	WO2002032893A3 Piperidine compounds as anti-allergic
08/22/2002	WO2002032404A3 Nanoparticles
08/22/2002	WO2002002773A3 Dual specificity antibodies and methods of making and using
08/22/2002	WO2001087328A3 Interleukin-1 inhibitors in the treatment of diseases
08/22/2002	WO2001085204A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
08/22/2002	WO2001085203A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
08/22/2002	WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof
08/22/2002	WO2000024907A9 Library of novel "unnatural" natural products
08/22/2002	WO2000023092A9 Contulakin-g, analogs thereof and uses therefor
08/22/2002	WO1999058143A9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
08/22/2002	US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole
08/22/2002	US20020115848 IBD-associated microbial nucleic acid molecules
08/22/2002	US20020115825 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier
08/22/2002	US20020115727 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
08/22/2002	US20020115726 Methods and compositions for treating depression and other disorders using optically pure (-) -bupropion
08/22/2002	US20020115716 Oral low dose butyrate compositions
08/22/2002	US20020115709 Atorvastatin hemi-calcium form VII
08/22/2002	US20020115691 S-rabeprazole compositions and methods
08/22/2002	US20020115684 2, 7-naphthyridine derivatives
08/22/2002	US20020115683 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
08/22/2002	US20020115677 Such as a combretastatin
08/22/2002	US20020115667 Treatment of disorders associated with glycolipid accumulation, such as Niemann-Pick Type C disease by administering an inhibitor of glucosylceramide synthesis, such as N-butyldeoxynojirimycin
08/22/2002	US20020115662 Delta-opioid or mu-opioid receptor modulators; useful analgesics, immunosuppressants, antiinflammatory agents, agents for the treatment of respiratory diseases.
08/22/2002	US20020115656 Administering 2-(1-(3-(5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo-(4,3 -c)pyridin-1-yl)-2-hydroxy-propyl)-piperidin-4-ylamino)-benzonitrile for inhibiting cathepsins; for treating atopic diseases
08/22/2002	US20020115644 Tetracycline compounds for treatment of Cryptosporidium parvum related disorders
08/22/2002	US20020115641 Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers
08/22/2002	US20020115616 Inhibit beta-secretase to reduce beta amyloid peptide concentrations and reduce the amyloid plaques and neuro-fibrillary tangles; Alzheimer's disease; stroke; Down' syndrome; amyotrophic lateral sclerosis; brain disorders
08/22/2002	US20020115610 Isolated polypeptides that stimulate gastrointestinal smooth muscle contraction, including human; ionotropic agents; enhanced gastrointestinal motility; identifying a prokineticin receptor ligand; calcium mobilization
08/22/2002	US20020115205 Receptor protein for use in the treatment of cancer, infections, psoraisis, asthma, allergies, viral diseases, arteriosclerosis, gland, eye, autoimmune, nervous system and psychological disorders
08/22/2002	US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents
08/22/2002	US20020115115 Uses of mammalian genes and related reagents
08/22/2002	US20020115102 Novel protein
08/22/2002	US20020115061 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c viris
08/22/2002	US20020114802 Oral immunoglobulin treatment for inflammatory bowel disease
08/22/2002	US20020114781 Interleukin antagonists for suppressing autoimmune respone via reducing number of antigen-reactive lymphocytes; treatment of rheumatic diseases
08/22/2002	CA2438590A1 Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1
08/22/2002	CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/22/2002	CA2437643A1 Matrix metalloproteinase inhibitors
08/22/2002	CA2437588A1 Triazolo compounds as mmp inhibitors
08/22/2002	CA2437576A1 Method for evaluating therapeutic efficacy
08/22/2002	CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors
08/22/2002	CA2437122A1 Quinazolines as mmp-13 inhibitors
08/22/2002	CA2437118A1 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
08/22/2002	CA2436371A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
08/22/2002	CA2436195A1 Laulimalide derivatives
08/22/2002	CA2435376A1 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
08/22/2002	CA2434835A1 Novel modified released formulation
08/22/2002	CA2434542A1 Novel modified release formulation
08/22/2002	CA2433843A1 Molecules for disease detection and treatment
08/22/2002	CA2433075A1 Benzo thiadiazine matrix metalloproteinase inhibitors
08/22/2002	CA2427112A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
08/21/2002	EP1233021A2 An inhibitor of Beta amyloid cleavage enzyme
08/21/2002	EP1233013A1 Novel phenylalanine derivatives
08/21/2002	EP1232751A1 Remedies for periodontosis
08/21/2002	EP1232748A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof
08/21/2002	EP1232267A2 Activation of hcv-specific t cells
08/21/2002	EP1232266A2 Polypeptides and nucleic acids encoding same
08/21/2002	EP1232264A2 Human fgf-21 gene and gene expression products
08/21/2002	EP1232259A1 Human galanin family proteins and polynucleotides encoding the same
08/21/2002	EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
08/21/2002	EP1232155A1 Protease inhibitors
08/21/2002	EP1232154A1 Protease inhibitors
08/21/2002	EP1232150A1 Urea derivatives as anti-inflammatory agents
08/21/2002	EP1232147A1 Triazoles as farnesyl transferase inhibitors
08/21/2002	EP1232144A2 Novel il-8 receptor antagonists
08/21/2002	EP1231982A2 Use of phthalazine derivatives
08/21/2002	EP1231941A1 Tablets comprising micro-organisms and method for preparation of the tablets
08/21/2002	EP1231933A1 An aqueous solution formulation of alpha-interferon
08/21/2002	EP1231931A2 Methods of treating inflammatory bowel disease using cholera toxin b subunit
08/21/2002	EP1231923A1 Protease inhibitors
08/21/2002	EP1231922A1 Protease inhibitors
08/21/2002	EP1231921A1 Protease inhibitors
08/21/2002	EP1231913A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
08/21/2002	EP1231907A2 Dextrose and insulin fluid formulation for intravenous infusion
08/21/2002	EP1041991A4 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
08/21/2002	EP0866654A4 Method for treating hepatitis virus infection
08/21/2002	EP0637203B1 Regulation of the immune system
08/21/2002	CN1365283A Unfermented gel fraction from psyllium seed husks
08/21/2002	CN1365281A Metalloprotease inhibitors
08/21/2002	CN1365276A Method for treating eating disorders
08/21/2002	CN1364644A Immuno liposome therapeutic hepatitis B vaccine and its preparing method
08/21/2002	CN1364629A Traditional Chinese medicine for curing gastroptosis and gastric ulcer
08/21/2002	CN1364628A Compound traditional Chinese dmedicine preparation-Manxiening pill for curing chronic diarrhea
08/21/2002	CN1364626A Chinese herbal medicine formula for curing cholecystitis
08/21/2002	CN1364623A Medicine for curing constipation and its preparing method
08/21/2002	CN1364616A Tea tree mushroom compound capsule, granule and oral liquor and the producing method
08/21/2002	CN1364603A Nano Poria and bighead atractylodes rhizome medicine and its preparing method
08/21/2002	CN1364602A Nano powerful tonic medicine and its preparing method
08/21/2002	CN1364599A Nano blood tonifying medicine and its preparing method

1 ... 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 ... 1258